Key result
Direct current cardioversion restores sinus rhythm in ~87% of anticoagulated AF patients.
Why the study?
Patients with AF are at increased risk of cardiovascular diseases and death, and evidence comparing rhythm and heart rate control strategies remains ambiguous.
Cohort (n=226)
No
Answers are grounded in this paper and cite their sources.
May support DCCV safety under anticoagulation in AF; leaves open strategies to reduce high recurrence.
Introduction Patients with atrial fibrillation (AF) are at increased risk of cardiovascular diseases and death. Evidence on the comparable effects of rhythm and heart rate control strategies in patients with AF is ambiguous. Aim of the research To assess the recurrence of arrhythmia and adverse cardiovascular events within 12 months of electrical cardioversion in patients with AF receiving oral anticoagulation therapy. Material and methods This was a prospective, single-centre cohort study. The participants underwent transoesophageal echocardiography before direct current cardioversion (DCC). A total of 226 patients were enrolled. The primary outcome was sinus rhythm (SR) restoration after DCC for AF. All participants were followed up for 12 months to evaluate the incidence of death, systemic thromboembolic events, stroke, acute coronary syndrome, hospitalization due to worsening heart failure (HF), and recurrence of arrhythmia after SR restoration. Results SR restoration was achieved after DCC in 197 (87.2 %) patients, of whom 112 (56.9%) experienced arrhythmia relapse. Significant risk factors associated with arrhythmia recurrence were -adrenergic antagonist therapy, chronic obstructive pulmonary disease, and previous stroke/transient ischaemic attack/thromboembolic events. All enrolled patients were free of acute coronary syndrome, systemic thromboembolic events, and stroke, and none of the patients died during the 12-month follow-up period. Hospitalization with worsening HF occurred in 13 patients with SR and in 10 patients with persistent AF (p = 0.42). Conclusions The arrhythmia recurrence rate was high; however, cardiovascular complications and deaths did not occur. The incidence of hospitalization for HF was comparable between the AF and SR groups.
No takes yet. Share an insight, caveat, or question.
Turek et al. (2022) conducted a cohort in Atrial fibrillation (n=226). Direct current cardioversion (DCC) and antiarrhythmic drug therapy was evaluated on Sinus rhythm restoration after direct current cardioversion. Direct current cardioversion restored sinus rhythm in 87.2% of anticoagulated atrial fibrillation patients, though 56.9% had recurrence and zero deaths or strokes occurred over 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: